Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

March 01, 1990; Volume 252,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abraham, R T

    1. You have access
      Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;
  2. Abrahamsson, T

    1. You have access
      Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.
      V Nerme, T Abrahamsson and G Vauquelin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1341-1346;
  3. Adham, N

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
  4. Althaus, W A

    1. You have access
      Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;
  5. Austin, M C

    1. You have access
      Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum.
      M C Austin and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1370-1377;

B

  1. Baker, R C

    1. You have access
      Ethanol inhibits zymosan-stimulated and enhances nonstimulated platelet-activating factor production in a clonal macrophage cell line.
      R C Baker, M Tucker and K L Clay
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1028-1033;
  2. Balster, R L

    1. You have access
      The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
      P M Beardsley, B A Hayes and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 953-959;
  3. Barnes, P J

    1. You have access
      A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways.
      M Ichinose and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1207-1212;
  4. Barnette, M S

    1. You have access
      Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;
  5. Barrington, P L

    1. You have access
      Characterization of the electrophysiological effects of metoprolol on isolated feline ventricular myocytes.
      P L Barrington and R E Ten Eick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1043-1052;
  6. Beardsley, P M

    1. You have access
      The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
      P M Beardsley, B A Hayes and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 953-959;
  7. Bhargava, H N

    1. You have access
      Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
      H N Bhargava and A Gulati
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 901-907;
  8. Billah, M M

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  9. Bjur, R A

    1. You have access
      Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;
  10. Bloom, A S

    1. You have access
      Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;
  11. Bloxham, D P

    1. You have access
      Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;
  12. Blue, D R

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
  13. Boarder, M R

    1. You have access
      Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;
  14. Boisse, N R

    1. You have access
      Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;
  15. Bond, R A

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
  16. Boyer, D R

    1. You have access
      Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;
  17. Bradshaw, D

    1. You have access
      Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;
  18. Brady, J V

    1. You have access
      Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;
  19. Brater, D C

    1. You have access
      Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
      K A Kirchner, J R Voelker and D C Brater
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1097-1101;
  20. Breeding, M

    1. You have access
      Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
      E Sanders-Bush and M Breeding
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 984-988;
  21. Breese, G R

    1. You have access
      Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

C

  1. Caliezi, A

    1. You have access
      Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;
  2. Cashin, C H

    1. You have access
      Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;
  3. Cass, W A

    1. You have access
      Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;
  4. Caudle, R M

    1. You have access
      Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
      R M Caudle and C Chavkin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1361-1369;
  5. Cavero, I

    1. You have access
      Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
      L Tahraoui, A Floch and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1221-1227;
  6. Chapman, R W

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  7. Chavkin, C

    1. You have access
      Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
      R M Caudle and C Chavkin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1361-1369;
  8. Cheng, H Y

    1. You have access
      Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;
  9. Ciaranello, R D

    1. You have access
      G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain.
      R D Ciaranello, G L Tan and R Dean
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1347-1354;
  10. Cipkus-Dubray, L A

    1. You have access
      Factors affecting rabbit mesenteric artery smooth muscle sensitivity to calcium antagonists.
      K D Meisheri, G P Sage and L A Cipkus-Dubray
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1167-1174;
  11. Clarke, D E

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
    2. You have access
      Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
      D A Craig and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1378-1386;
  12. Clay, K L

    1. You have access
      Ethanol inhibits zymosan-stimulated and enhances nonstimulated platelet-activating factor production in a clonal macrophage cell line.
      R C Baker, M Tucker and K L Clay
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1028-1033;
  13. Craft, R M

    1. You have access
      Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 945-952;
  14. Cragoe, E J

    1. You have access
      Modulation of bovine aortic alpha-2 receptors by Na+, 5'-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor G-protein precoupling.
      G Jagadeesh, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1184-1196;
  15. Craig, D A

    1. You have access
      Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
      D A Craig and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1378-1386;

D

  1. Dadan, J

    1. You have access
      Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;
  2. Dean, R

    1. You have access
      G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain.
      R D Ciaranello, G L Tan and R Dean
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1347-1354;
  3. Delmendo, R

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
  4. De Paulis, T

    1. You have access
      Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;
  5. Deth, R C

    1. You have access
      Modulation of bovine aortic alpha-2 receptors by Na+, 5'-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor G-protein precoupling.
      G Jagadeesh, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1184-1196;
  6. Dodge, B B

    1. You have access
      Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;
  7. Drack, E

    1. You have access
      Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;
  8. Drieman, J C

    1. You have access
      Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole.
      J C Drieman, H H Thijssen and H A Struyker-Boudier
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1255-1260;
  9. Drummer, O H

    1. You have access
      Biliary excretion and conjugation of diacid angiotensin-converting enzyme inhibitors.
      O H Drummer, J Nicolaci and D Iakovidis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1202-1206;
  10. Duncan, G E

    1. You have access
      Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;
  11. Dunwiddie, T V

    1. You have access
      Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;
  12. Dykstra, L A

    1. You have access
      Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 945-952;

E

  1. Egan, R W

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  2. Eglen, R M

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
  3. Evans, S M

    1. You have access
      Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

F

  1. Fenwick, J W

    1. You have access
      Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;
  2. Fischman, M W

    1. You have access
      Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;
  3. Flavahan, N A

    1. You have access
      Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;
  4. Floch, A

    1. You have access
      Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
      L Tahraoui, A Floch and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1221-1227;
  5. Foltin, R W

    1. You have access
      Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;
    2. You have access
      Differential development of tolerance to the effects of d-amphetamine and fenfluramine on food intake in baboons.
      R W Foltin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 960-969;
  6. Fujimoto, S

    1. You have access
      Effects of pimobendan, a cardiotonic and vasodilating agent with phosphodiesterase inhibiting properties, on isolated arteries and veins of rats.
      S Fujimoto and T Matsuda
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1304-1311;
  7. Fujiwara, M

    1. You have access
      The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes.
      M Okada, K Mine and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1283-1288;
  8. Furukawa, O

    1. You have access
      Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;
  9. Furuya, Y

    1. You have access
      Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

G

  1. Gabanelli, M

    1. You have access
      Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;
  2. Gan, B S

    1. You have access
      Distinct coronary artery receptor systems for epidermal growth factor-urogastrone.
      B S Gan and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1277-1282;
  3. Gilchrest, H

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  4. Giuliani, S

    1. You have access
      Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;
  5. Goyal, R K

    1. You have access
      Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
      J K Saha, J N Sengupta and R K Goyal
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1012-1020;
  6. Griffiths, R R

    1. You have access
      Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;
  7. Grous, M

    1. You have access
      Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;
  8. Guarino, J J

    1. You have access
      Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;
  9. Gulati, A

    1. You have access
      Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
      H N Bhargava and A Gulati
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 901-907;
  10. Gust, S W

    1. You have access
      Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;

H

  1. Halter, F

    1. You have access
      Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;
  2. Hayashi, K

    1. You have access
      Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;
  3. Hayes, B A

    1. You have access
      The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
      P M Beardsley, B A Hayes and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 953-959;
  4. Heishman, S J

    1. You have access
      Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;
  5. Henningsen, R A

    1. You have access
      Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;
  6. Heyman, J S

    1. You have access
      Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;
  7. Hillard, C J

    1. You have access
      Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;
  8. Hisaki, K

    1. You have access
      Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;
  9. Hoke, G D

    1. You have access
      Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;
  10. Hollenberg, M D

    1. You have access
      Distinct coronary artery receptor systems for epidermal growth factor-urogastrone.
      B S Gan and M D Hollenberg
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1277-1282;
  11. Hong, J S

    1. You have access
      Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;
  12. Hughes, J R

    1. You have access
      Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;

I

  1. Iakovidis, D

    1. You have access
      Biliary excretion and conjugation of diacid angiotensin-converting enzyme inhibitors.
      O H Drummer, J Nicolaci and D Iakovidis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1202-1206;
  2. Ichinose, M

    1. You have access
      A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways.
      M Ichinose and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1207-1212;
  3. Inoki, R

    1. You have access
      Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;

J

  1. Jagadeesh, G

    1. You have access
      Modulation of bovine aortic alpha-2 receptors by Na+, 5'-guanylylimidodiphosphate, amiloride and ethylisopropylamiloride: evidence for receptor G-protein precoupling.
      G Jagadeesh, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1184-1196;
  2. Janowsky, A

    1. You have access
      Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;
  3. Johns, R A

    1. You have access
      Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;
  4. Jones, J A

    1. You have access
      Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;

K

  1. Kalivas, P W

    1. You have access
      Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum.
      M C Austin and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1370-1377;
  2. Kanai, Y

    1. You have access
      Antagonism of gamma-aminobutyric acidA receptor-mediated responses by amino-gamma-carbolines.
      Y Kanai, O Wada and S Manabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1269-1276;
  3. Kaneko, T

    1. You have access
      Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;
  4. Kaplan, D S

    1. You have access
      Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;
  5. Kau, D

    1. You have access
      Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;
  6. Kauffman, F C

    1. You have access
      O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;
  7. Kawai, Y

    1. You have access
      Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide.
      Y Kawai and T Ohhashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1234-1239;
  8. Keenan, R M

    1. You have access
      Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.
      J R Hughes, S W Gust, R M Keenan and J W Fenwick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1175-1183;
  9. Keller, B J

    1. You have access
      O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;
  10. Kelly, T H

    1. You have access
      Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;
  11. Kessler, R M

    1. You have access
      Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;
  12. Killam, A L

    1. You have access
      Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;
  13. King, R L

    1. You have access
      Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;
  14. Kinzie, J M

    1. You have access
      Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;
  15. Kirchner, K A

    1. You have access
      Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
      K A Kirchner, J R Voelker and D C Brater
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1097-1101;
  16. Komori, K

    1. You have access
      Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;
  17. Koslo, R J

    1. You have access
      Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;
  18. Kreutner, W

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  19. Kuhn, C

    1. You have access
      Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

L

  1. Lambert, G M

    1. You have access
      Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;
  2. Levine, R A

    1. You have access
      Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;
  3. Lewis, E J

    1. You have access
      Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;
  4. Liang, D C

    1. You have access
      O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;
  5. Linden, J

    1. You have access
      Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;
  6. Lindstrom, T D

    1. You have access
      Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;
  7. Lippe, I T

    1. You have access
      Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;
  8. Lupica, C R

    1. You have access
      Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;

M

  1. Maggi, C A

    1. You have access
      Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;
  2. Maki, Y

    1. You have access
      Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
      H Nagaya, H Satoh and Y Maki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1289-1295;
  3. Manabe, S

    1. You have access
      Antagonism of gamma-aminobutyric acidA receptor-mediated responses by amino-gamma-carbolines.
      Y Kanai, O Wada and S Manabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1269-1276;
  4. Marriott, D B

    1. You have access
      Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;
  5. Martin, A R

    1. You have access
      Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;
  6. Matsuda, T

    1. You have access
      Effects of pimobendan, a cardiotonic and vasodilating agent with phosphodiesterase inhibiting properties, on isolated arteries and veins of rats.
      S Fujimoto and T Matsuda
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1304-1311;
  7. Matsumura, Y

    1. You have access
      Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;
  8. Meisheri, K D

    1. You have access
      Factors affecting rabbit mesenteric artery smooth muscle sensitivity to calcium antagonists.
      K D Meisheri, G P Sage and L A Cipkus-Dubray
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1167-1174;
  9. Meli, A

    1. You have access
      Dual effects of cholecystokinin-octapeptide on duodenal motility of urethane-anesthetized rats.
      S Giuliani, I T Lippe, C A Maggi and A Meli
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1312-1317;
  10. Michel, A D

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
  11. Miller, V M

    1. You have access
      Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;
  12. Mine, K

    1. You have access
      The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes.
      M Okada, K Mine and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1283-1288;
  13. Mirabelli, C K

    1. You have access
      Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;
  14. Mok, L L

    1. You have access
      Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
      E E Reynolds and L L Mok
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 915-921;
  15. Morimoto, S

    1. You have access
      Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;
  16. Morón, M A

    1. You have access
      The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
      M A Morón, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1150-1155;
  17. Mueller, R A

    1. You have access
      Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;

N

  1. Nagaya, H

    1. You have access
      Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
      H Nagaya, H Satoh and Y Maki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1289-1295;
  2. Nakazawa, T

    1. You have access
      Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;
  3. Nandi, J

    1. You have access
      Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
      J Nandi, R L King, D S Kaplan and R A Levine
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1102-1107;
  4. Narahashi, T

    1. You have access
      Potent blocking action of chlorpromazine on two types of calcium channels in cultured neuroblastoma cells.
      N Ogata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1142-1149;
  5. Nelson, D L

    1. You have access
      Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;
  6. Nerme, V

    1. You have access
      Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.
      V Nerme, T Abrahamsson and G Vauquelin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1341-1346;
  7. Neve, K A

    1. You have access
      Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;
  8. Ngai, J H

    1. You have access
      Effects of endothelium on basal tone and agonist and O2 sensitivity in porcine coronary artery.
      J H Ngai, P S Roth and R J Paul
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1053-1059;
  9. Nicolaci, J

    1. You have access
      Biliary excretion and conjugation of diacid angiotensin-converting enzyme inhibitors.
      O H Drummer, J Nicolaci and D Iakovidis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1202-1206;
  10. Niida, H

    1. You have access
      Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;
  11. Nikam, S S

    1. You have access
      Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
      A L Killam, S S Nikam, G M Lambert, A R Martin and D L Nelson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1083-1089;

O

  1. O'Donnell, S R

    1. You have access
      Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations.
      S R O'Donnell, J C Wanstall and X P Zeng
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1318-1323;
  2. Oakes, S G

    1. You have access
      Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;
  3. Ogata, N

    1. You have access
      Potent blocking action of chlorpromazine on two types of calcium channels in cultured neuroblastoma cells.
      N Ogata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1142-1149;
  4. Ohhashi, T

    1. You have access
      Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide.
      Y Kawai and T Ohhashi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1234-1239;
  5. Ohkubo, T

    1. You have access
      Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;
  6. Ohyama, T

    1. You have access
      Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;
  7. Okabe, S

    1. You have access
      Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;
  8. Okada, M

    1. You have access
      Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;
    2. You have access
      The Na(+)-dependent release of endogenous dopamine and noradrenaline from rat brain synaptosomes.
      M Okada, K Mine and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1283-1288;
  9. Ormsbee, H S

    1. You have access
      Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;
  10. Owen, P J

    1. You have access
      Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;

P

  1. Page, R D

    1. You have access
      Prostaglandin F2 alpha inhibits acidification in H(+)-secreting epithelia.
      R D Page and T Yorio
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 929-933;
  2. Paul, I A

    1. You have access
      Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
      I A Paul, G E Duncan, C Kuhn, R A Mueller, J S Hong and G R Breese
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 997-1005;
  3. Paul, R J

    1. You have access
      Effects of endothelium on basal tone and agonist and O2 sensitivity in porcine coronary artery.
      J H Ngai, P S Roth and R J Paul
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1053-1059;
  4. Peach, M J

    1. You have access
      Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;
  5. Perico, N

    1. You have access
      Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;
  6. Piwinski, J J

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  7. Plevin, R

    1. You have access
      Role of phosphoinositide turnover and cyclic AMP accumulation in prostaglandin-stimulated noradrenaline release from cultured adrenal chromaffin cells.
      R Plevin, P J Owen, D B Marriott, J A Jones and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1296-1303;
  8. Porreca, F

    1. You have access
      Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;
  9. Pounds, J J

    1. You have access
      Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
      C J Hillard, J J Pounds, D R Boyer and A S Bloom
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1075-1082;
  10. Powis, G

    1. You have access
      Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;
  11. Preston, K L

    1. You have access
      Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;
  12. Puig, M M

    1. You have access
      Effect of pertussis toxin on the interaction of azepexole and halothane.
      M M Puig, H Turndorf and W Warner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1156-1159;

Q

  1. Qi, J A

    1. You have access
      Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;
  2. Quaglietta, N

    1. You have access
      Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;

R

  1. Rabin, R A

    1. You have access
      Chronic ethanol exposure of PC 12 cells alters adenylate cyclase activity and intracellular cyclic AMP content.
      R A Rabin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1021-1027;
  2. Remuzzi, G

    1. You have access
      Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin.
      N Perico, J Dadan, M Gabanelli and G Remuzzi
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1213-1220;
  3. Reynolds, E E

    1. You have access
      Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
      E E Reynolds and L L Mok
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 915-921;
  4. Rose, A J

    1. You have access
      Smoked marijuana effects on tobacco cigarette smoking behavior.
      T H Kelly, R W Foltin, A J Rose, M W Fischman and J V Brady
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 934-944;
  5. Roth, P S

    1. You have access
      Effects of endothelium on basal tone and agonist and O2 sensitivity in porcine coronary artery.
      J H Ngai, P S Roth and R J Paul
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1053-1059;
  6. Roth, R H

    1. You have access
      Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization.
      S Y Tam and R H Roth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 989-996;
  7. Roy, D

    1. You have access
      Covalent binding of phenytoin to protein and modulation of phenytoin metabolism by thiols in A/J mouse liver microsomes.
      D Roy and W R Snodgrass
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 895-900;
  8. Rush, G F

    1. You have access
      Mechanism of inhibition of rat liver mitochondrial respiration by oxmetidine, an H2-receptor antagonist.
      G D Hoke, H Y Cheng, C K Mirabelli and G F Rush
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 908-914;
  9. Ruterbories, K J

    1. You have access
      Pharmacokinetics and disposition of the KS1/4 monoclonal antibody-desacetylvinblastine hydrazide conjugate LY203725 in rats and monkeys.
      T D Lindstrom, W A Althaus, K J Ruterbories and D Kau
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1117-1124;

S

  1. Sage, G P

    1. You have access
      Factors affecting rabbit mesenteric artery smooth muscle sensitivity to calcium antagonists.
      K D Meisheri, G P Sage and L A Cipkus-Dubray
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1167-1174;
  2. Saha, J K

    1. You have access
      Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
      J K Saha, J N Sengupta and R K Goyal
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1012-1020;
  3. Samoriski, G M

    1. You have access
      Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
      N R Boisse, N Quaglietta, G M Samoriski and J J Guarino
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1125-1133;
  4. Sanders-Bush, E

    1. You have access
      Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
      E Sanders-Bush and M Breeding
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 984-988;
  5. Sannerud, C A

    1. You have access
      Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;
  6. Santone, K S

    1. You have access
      Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;
  7. Satoh, H

    1. You have access
      Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
      H Nagaya, H Satoh and Y Maki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1289-1295;
  8. Scheurer, U

    1. You have access
      Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;
  9. Schlager, J J

    1. You have access
      Doxorubicin blocks the increase in intracellular Ca++, part of a second messenger system in N1E-115 murine neuroblastoma cells.
      S G Oakes, J J Schlager, K S Santone, R T Abraham and G Powis
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 979-983;
  10. Schmidt, D E

    1. You have access
      Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
      K A Neve, R A Henningsen, J M Kinzie, T De Paulis, D E Schmidt, R M Kessler and A Janowsky
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1108-1116;
  11. Sedaa, K O

    1. You have access
      Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;
  12. Self, C R

    1. You have access
      Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;
  13. Sengupta, J N

    1. You have access
      Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
      J K Saha, J N Sengupta and R K Goyal
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1012-1020;
  14. Sheldon, R J

    1. You have access
      Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
      J A Qi, J S Heyman, R J Sheldon, R J Koslo and F Porreca
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1006-1011;
  15. Sherwood, J

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  16. Shibata, M

    1. You have access
      Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;
  17. Shinozuka, K

    1. You have access
      Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;
  18. Siegel, M I

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  19. Singer, H A

    1. You have access
      Phorbol ester-induced stress and myosin light chain phosphorylation in swine carotid medial smooth muscle.
      H A Singer
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1068-1074;
  20. Snodgrass, W R

    1. You have access
      Covalent binding of phenytoin to protein and modulation of phenytoin metabolism by thiols in A/J mouse liver microsomes.
      D Roy and W R Snodgrass
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 895-900;
  21. Stevens, C W

    1. You have access
      The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
      M A Morón, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1150-1155;
  22. Struyker-Boudier, H A

    1. You have access
      Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole.
      J C Drieman, H H Thijssen and H A Struyker-Boudier
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1255-1260;
  23. Suzuki, Y

    1. You have access
      Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;

T

  1. Tachibana, S

    1. You have access
      Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;
  2. Tahraoui, L

    1. You have access
      Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
      L Tahraoui, A Floch and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1221-1227;
  3. Takahashi, H

    1. You have access
      Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
      T Ohkubo, M Shibata, H Takahashi and R Inoki
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1261-1268;
  4. Takeuchi, K

    1. You have access
      Influences of stress on gastric alkaline secretion in rats.
      K Takeuchi, O Furukawa, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1228-1233;
  5. Tam, S Y

    1. You have access
      Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization.
      S Y Tam and R H Roth
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 989-996;
  6. Tan, G L

    1. You have access
      G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain.
      R D Ciaranello, G L Tan and R Dean
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1347-1354;
  7. Ten Eick, R E

    1. You have access
      Characterization of the electrophysiological effects of metoprolol on isolated feline ventricular myocytes.
      P L Barrington and R E Ten Eick
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1043-1052;
  8. Thijssen, H H

    1. You have access
      Renal selective N-acetyl-gamma-glutamyl prodrugs. II. Carrier-mediated transport and intracellular conversion as determinants in the renal selectivity of N-acetyl-gamma-glutamyl sulfamethoxazole.
      J C Drieman, H H Thijssen and H A Struyker-Boudier
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1255-1260;
  9. Thurman, R G

    1. You have access
      O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;
  10. Torphy, T J

    1. You have access
      Activation of cyclic AMP-dependent protein kinase during canine lower esophageal sphincter relaxation.
      M S Barnette, M Grous, T J Torphy and H S Ormsbee
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1160-1166;
  11. Tracey, W R

    1. You have access
      Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
      W R Tracey, J Linden, M J Peach and R A Johns
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 922-928;
  12. Tucker, M

    1. You have access
      Ethanol inhibits zymosan-stimulated and enhances nonstimulated platelet-activating factor production in a clonal macrophage cell line.
      R C Baker, M Tucker and K L Clay
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1028-1033;
  13. Turndorf, H

    1. You have access
      Effect of pertussis toxin on the interaction of azepexole and halothane.
      M M Puig, H Turndorf and W Warner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1156-1159;

V

  1. Vanhoutte, P M

    1. You have access
      Electrophysiological analysis of adrenergic neurotransmission and its modulation by chronic denervation in canine saphenous veins.
      K Komori, N A Flavahan, V M Miller and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1197-1201;
  2. Varga, L

    1. You have access
      Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;
  3. Vauquelin, G

    1. You have access
      Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.
      V Nerme, T Abrahamsson and G Vauquelin
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1341-1346;
  4. Voelker, J R

    1. You have access
      Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
      K A Kirchner, J R Voelker and D C Brater
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1097-1101;

W

  1. Wada, O

    1. You have access
      Antagonism of gamma-aminobutyric acidA receptor-mediated responses by amino-gamma-carbolines.
      Y Kanai, O Wada and S Manabe
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1269-1276;
  2. Wanstall, J C

    1. You have access
      Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations.
      S R O'Donnell, J C Wanstall and X P Zeng
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1318-1323;
  3. Warner, W

    1. You have access
      Effect of pertussis toxin on the interaction of azepexole and halothane.
      M M Puig, H Turndorf and W Warner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1156-1159;
  4. Wenger, F

    1. You have access
      Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
      U Scheurer, F Wenger, A Caliezi, E Drack, L Varga and F Halter
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1324-1330;
  5. West, R E

    1. You have access
      Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
      M M Billah, R W Chapman, R W Egan, H Gilchrest, J J Piwinski, J Sherwood, M I Siegel, R E West and W Kreutner
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1090-1096;
  6. Westfall, D P

    1. You have access
      Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta.
      K O Sedaa, R A Bjur, K Shinozuka and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1060-1067;
  7. Westmacott, D

    1. You have access
      Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
      D P Bloxham, D Bradshaw, C H Cashin, B B Dodge, E J Lewis, D Westmacott and C R Self
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1331-1340;
  8. Whiting, R L

    1. You have access
      Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
      D R Blue, R A Bond, N Adham, R Delmendo, A D Michel, R M Eglen, R L Whiting and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1034-1042;
  9. Wolf, B

    1. You have access
      Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;
  10. Woodson, P P

    1. You have access
      Low-dose caffeine discrimination in humans.
      R R Griffiths, S M Evans, S J Heishman, K L Preston, C A Sannerud, B Wolf and P P Woodson
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 970-978;

Y

  1. Yaksh, T L

    1. You have access
      The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
      M A Morón, C W Stevens and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1150-1155;
  2. Yamanaka, H

    1. You have access
      O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action.
      B J Keller, H Yamanaka, D C Liang, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1355-1360;
  3. Yamatsu, K

    1. You have access
      Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;
  4. Yorio, T

    1. You have access
      Prostaglandin F2 alpha inhibits acidification in H(+)-secreting epithelia.
      R D Page and T Yorio
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 929-933;
  5. Yoshida, Y

    1. You have access
      Effects of BRL 34915 (cromakalim) on renal hemodynamics and function in anesthetized dogs.
      K Hayashi, Y Matsumura, Y Yoshida, T Ohyama, K Hisaki, Y Suzuki and S Morimoto
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1240-1246;
  6. Yoshino, H

    1. You have access
      Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
      T Nakazawa, Y Furuya, T Kaneko, K Yamatsu, H Yoshino and S Tachibana
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1247-1254;

Z

  1. Zahniser, N R

    1. You have access
      Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
      C R Lupica, W A Cass, N R Zahniser and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1134-1141;
  2. Zeng, X P

    1. You have access
      Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations.
      S R O'Donnell, J C Wanstall and X P Zeng
      Journal of Pharmacology and Experimental Therapeutics March 1990, 252 (3) 1318-1323;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 252, Issue 3
1 Mar 1990
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics